Bankole A. Johnson's most recent trade in Adial Pharmaceuticals Inc was a trade of 40,000 Stock Option done . Disclosure was reported to the exchange on May 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adial Pharmaceuticals Inc | Bankole A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 40,000 | 40,000 | - | - | Stock Option | |
| Adial Pharmaceuticals Inc | Bankole A. Johnson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 35,000 | 35,000 | - | - | Employee Stock Option | |
| Adial Pharmaceuticals Inc | Bankole A. Johnson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Oct 2021 | 200,000 | 148,246 (1%) | 1% | - | Common Stock | |
| Adial Pharmaceuticals Inc | Bankole A. Johnson | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 04 Oct 2021 | 150,000 | 39,714 | - | - | Warrant | |
| Adial Pharmaceuticals Inc | Bankole A. Johnson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 06 Apr 2021 | 150,000 | 548,336 (5%) | 1% | 2.5 | 375,000 | Common Stock |
| Adial Pharmaceuticals Inc | Bankole A. Johnson | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 20 Aug 2020 | 350,000 | 1,055 (0%) | 3% | 1.2 | 423,500 | Common Stock |